These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29547014)

  • 1. Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus.
    Spectre G; Mobarrez F; Stålesen R; Östenson CG; Varon D; Wallen H; Hjemdahl P
    Platelets; 2019; 30(3):348-355. PubMed ID: 29547014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.
    Almquist T; Mobarrez F; Jacobson SH; Wallén H; Hjemdahl P
    Nephrol Dial Transplant; 2016 Jun; 31(6):944-52. PubMed ID: 26394646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
    Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
    Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis.
    Li S; Wei J; Zhang C; Li X; Meng W; Mo X; Zhang Q; Liu Q; Ren K; Du R; Tian H; Li J
    Cell Physiol Biochem; 2016; 39(6):2439-2450. PubMed ID: 27832642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia.
    Mooberry MJ; Bradford R; Hobl EL; Lin FC; Jilma B; Key NS
    J Thromb Haemost; 2016 May; 14(5):1031-42. PubMed ID: 26857798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
    Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects.
    Enjeti AK; Ariyarajah A; D'Crus A; Seldon M; Lincz LF
    Thromb Res; 2016 Sep; 145():18-23. PubMed ID: 27429418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
    Zhao L; Bi Y; Kou J; Shi J; Piao D
    J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels.
    Spectre G; Stålesen R; Östenson CG; Hjemdahl P
    Thromb Res; 2016 May; 141():93-7. PubMed ID: 26994470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
    Christersson C; Thulin Å; Siegbahn A
    Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased phosphatidylserine-exposing microparticles and their originating cells are associated with the coagulation process in patients with IgA nephropathy.
    He Z; Zhang Y; Cao M; Ma R; Meng H; Yao Z; Zhao L; Liu Y; Wu X; Deng R; Dong Z; Bi Y; Kou J; Novakovic V; Shi J; Hao L
    Nephrol Dial Transplant; 2016 May; 31(5):747-59. PubMed ID: 26673909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of microparticles in patients with the antiphospholipid syndrome (APS).
    Vikerfors A; Mobarrez F; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Antovic A; Wallén H; Svenungsson E
    Lupus; 2012 Jun; 21(7):802-5. PubMed ID: 22635239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research.
    Rodrigues KF; Pietrani NT; Fernandes AP; Bosco AA; de Sousa MCR; de Fátima Oliveira Silva I; Silveira JN; Campos FMF; Gomes KB
    Clin Chim Acta; 2018 Apr; 479():48-55. PubMed ID: 29305843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.
    Van Der Meijden PE; Van Schilfgaarde M; Van Oerle R; Renné T; ten Cate H; Spronk HM
    J Thromb Haemost; 2012 Jul; 10(7):1355-62. PubMed ID: 22537188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylserine expressing microvesicles in relation to microvascular complications in type 1 diabetes.
    Bergen K; Mobarrez F; Jörneskog G; Wallén H; Tehrani S
    Thromb Res; 2018 Dec; 172():158-164. PubMed ID: 30447538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
    Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.